162 related articles for article (PubMed ID: 31835701)
1. Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome.
Sekretarska J; Szczepaniak J; Sosnowska M; Grodzik M; Kutwin M; Wierzbicki M; Jaworski S; Bałaban J; Daniluk K; Sawosz E; Chwalibog A; Strojny B
Materials (Basel); 2019 Dec; 12(24):. PubMed ID: 31835701
[TBL] [Abstract][Full Text] [Related]
2. Nanostructures of diamond, graphene oxide and graphite inhibit CYP1A2, CYP2D6 and CYP3A4 enzymes and downregulate their genes in liver cells.
Strojny B; Sawosz E; Grodzik M; Jaworski S; Szczepaniak J; Sosnowska M; Wierzbicki M; Kutwin M; Orlińska S; Chwalibog A
Int J Nanomedicine; 2018; 13():8561-8575. PubMed ID: 30587978
[TBL] [Abstract][Full Text] [Related]
3. Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes.
Fröhlich E; Kueznik T; Samberger C; Roblegg E; Wrighton C; Pieber TR
Toxicol Appl Pharmacol; 2010 Feb; 242(3):326-32. PubMed ID: 19909766
[TBL] [Abstract][Full Text] [Related]
4. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
[TBL] [Abstract][Full Text] [Related]
5. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
Schulz C; Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
[TBL] [Abstract][Full Text] [Related]
6. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
Usmani KA; Karoly ED; Hodgson E; Rose RL
Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain.
Booth Depaz IM; Toselli F; Wilce PA; Gillam EM
Drug Metab Dispos; 2015 Mar; 43(3):353-7. PubMed ID: 25504503
[TBL] [Abstract][Full Text] [Related]
8. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
[TBL] [Abstract][Full Text] [Related]
9. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
Hyland R; Roe EG; Jones BC; Smith DA
Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
[TBL] [Abstract][Full Text] [Related]
10. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase.
Crespi CL; Miller VP
Pharmacogenetics; 1997 Jun; 7(3):203-10. PubMed ID: 9241660
[TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
12. Analyses of CYP2C in porcine microsomes.
Skaanild MT; Friis C
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):487-92. PubMed ID: 18803635
[TBL] [Abstract][Full Text] [Related]
13. Potentiating effect of graphene nanomaterials on aromatic environmental pollutant-induced cytochrome P450 1A expression in the topminnow fish hepatoma cell line PLHC-1.
Lammel T; Boisseaux P; Navas JM
Environ Toxicol; 2015 Sep; 30(10):1192-204. PubMed ID: 24706484
[TBL] [Abstract][Full Text] [Related]
14. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
15. Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia.
Niemira M; Dastych J; Mazerska Z
Biochem Pharmacol; 2013 Jul; 86(2):231-41. PubMed ID: 23688499
[TBL] [Abstract][Full Text] [Related]
16. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
Yamazaki H; Shimada T
Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
[TBL] [Abstract][Full Text] [Related]
17. [Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro].
Pawłowska M; Augustin E
Postepy Hig Med Dosw (Online); 2011 Jun; 65():367-76. PubMed ID: 21734321
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
Baldwin SJ; Clarke SE; Chenery RJ
Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
[TBL] [Abstract][Full Text] [Related]
19. The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro.
Muschler E; Lal J; Jetter A; Rattay A; Zanger U; Zadoyan G; Fuhr U; Kirchheiner J
Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):374-9. PubMed ID: 19614891
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of sesamin by cytochrome P450 in human liver microsomes.
Yasuda K; Ikushiro S; Kamakura M; Ohta M; Sakaki T
Drug Metab Dispos; 2010 Dec; 38(12):2117-23. PubMed ID: 20851877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]